- Report
- November 2022
- 290 Pages
Global
From €3411EUR$3,600USD£2,879GBP
- Report
- October 2022
- 81 Pages
Europe
From €1421EUR$1,500USD£1,200GBP
- Report
- October 2022
- 87 Pages
Middle East, Africa
From €1421EUR$1,500USD£1,200GBP
- Report
- October 2022
- 72 Pages
North America
From €1421EUR$1,500USD£1,200GBP
- Report
- June 2022
- 307 Pages
Global
From €3411EUR$3,600USD£2,879GBP
- Report
- June 2022
- 109 Pages
Europe
From €1421EUR$1,500USD£1,200GBP
- Report
- May 2024
- 63 Pages
China
From €1038EUR$1,095USD£876GBP
- Report
- December 2023
- 70 Pages
Global
From €943EUR$995USD£796GBP
- Report
- June 2023
- 62 Pages
Global
From €1848EUR$1,950USD£1,559GBP
-
Journal - March 2025
Global
From €105EUR$111USD£88GBP
- Report
- December 2024
- 80 Pages
India
From €3317EUR$3,500USD£2,799GBP
- Report
- July 2024
- 89 Pages
From €2795EUR$2,950USD£2,359GBP
From €2132EUR$2,250USD£1,799GBP
- Report
- May 2024
- 97 Pages
From €2795EUR$2,950USD£2,359GBP
- Report
- May 2024
- 68 Pages
Colombia
From €2132EUR$2,250USD£1,799GBP
- Report
- July 2023
- 220 Pages
Global
€4354EUR$4,595USD£3,675GBP
- Report
- July 2023
- 210 Pages
Global
From €4264EUR$4,500USD£3,599GBP
- Report
- April 2023
- 118 Pages
Global
From €4501EUR$4,750USD£3,799GBP
- Report
- November 2022
- 138 Pages
Global
From €1895EUR$2,000USD£1,599GBP
- Directory
- August 2022
- 1046 Pages
Japan
From €9429EUR$9,950USD£7,957GBP

Biomedicine is a branch of biotechnology that focuses on the development of medical treatments and products. It involves the use of living organisms, such as bacteria, viruses, and cells, to create treatments and products that can be used to diagnose, prevent, and treat diseases. Biomedicine also includes the development of medical devices, such as prosthetics, and the use of genetic engineering to create new treatments.
Biomedicine is a rapidly growing field, with many companies investing in research and development. Companies in the biomedicine market are focused on developing treatments and products for a variety of diseases, including cancer, diabetes, and cardiovascular diseases. They are also working to develop treatments for rare diseases and to improve existing treatments.
Some of the companies in the biomedicine market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Celgene, Gilead Sciences, Johnson & Johnson, Merck, Novartis, Pfizer, and Roche. Show Less Read more